[C-11]NOP-1A PET
Showing 1 - 25 of >10,000
Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Alcohol Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh PET Facility
Jul 8, 2022
Chronic Pain Trial in New York ([11C]-NOP46, PET/CT scan)
Recruiting
- Chronic Pain
- [11C]-NOP46
- PET/CT scan
-
New York, New YorkColumbia University Irving Medical Center
Jul 2, 2021
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)
Completed
- Ketoses, Metabolic
- Observational heart and kidney on siemens TEP scan
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Jan 16, 2023
Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)
Recruiting
- Cocaine Use Disorder
- Baseline [C-11]NPA PET Scan
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh
Jun 27, 2022
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
Not yet recruiting
- Parkinson Disease
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2023
Pain, Anxiety, Depression Trial run by the NIMH (NOP-1A)
Completed
- Pain
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
Not yet recruiting
- Huntington Disease
- [11C]UCB-J
- [18F]SynVest-1
-
Leuven, BelgiumUZ Leuven
Nov 2, 2022
Healthy Trial in Pittsburgh (Hydrocortisone, [C-11]NOP-1A)
Completed
- Healthy
- Hydrocortisone
- [C-11]NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Oct 2, 2020
Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)
Active, not recruiting
- Melanoma
- FDG PET/CT scan
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Jan 10, 2023
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
Multiple Sclerosis, Inflammatory Demyelinating Disease Trial in Rochester (C-11 ER176 Radiotracer, C11 Pittsburgh Compound B,
Not yet recruiting
- Multiple Sclerosis
- Inflammatory Demyelinating Disease
- C-11 ER176 Radiotracer
- +3 more
-
Rochester, MinnesotaMayo Clinic Minnesota
Mar 28, 2023
HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)
Not yet recruiting
- HIV Associated Neurocognitive Disorder
- +3 more
- SV2A PET
- TSPO PET
- (no location specified)
Oct 16, 2022
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Mitral Valve Regurgitation Trial in Birmingham ([11C] acetate)
Recruiting
- Mitral Valve Regurgitation
- [11C] acetate
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 9, 2022
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Amyotrophic Lateral Sclerosis Trial in Baltimore ([11C]CPPC Injection)
Recruiting
- Amyotrophic Lateral Sclerosis
- [11C]CPPC Injection
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 11, 2022
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A
Recruiting
- Cocaine Use Disorder
- Healthy Controls
- 11C-UCB-J
-
New Haven, ConnecticutConnecticut Mental Health Center
Aug 10, 2022
Diabetes, Type 2, Heart Failure, Healthy Trial in Aarhus N (3-[11C]-OHB)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 3-[11C]-OHB
-
Aarhus N, Jutland, DenmarkAarhus University Hospital
Nov 1, 2022
Multiple Sclerosis Trial in London (PIPE-307)
Completed
- Multiple Sclerosis
-
London, United KingdomHammersmith Medicines Research
Oct 4, 2022
Bipolar Disorder Trial in New York (Ethyl Eicosapentaenoic Acid)
Withdrawn
- Bipolar Disorder
- Ethyl Eicosapentaenoic Acid
-
New York, New YorkNew York State Psychiatric Institute/Columbia University Medical
Oct 12, 2022
Mild Cognitive Impairment Trial in Philadelphia (11C-acetate)
Terminated
- Mild Cognitive Impairment
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Apr 11, 2022
Healthy Participants Trial in London ([11C]-Lu AF88370)
Completed
- Healthy Participants
- [11C]-Lu AF88370
-
London, United KingdomInvicro
Jul 12, 2022